Home › Attention Deficit Hyperactivity Disorder › Tennessee › Memphis
Attention Deficit Hyperactivity Disorder clinical trials in Memphis, TN
4 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
RecruitingPhase 4
- Clinical Neuroscience Solutions, Inc., Memphis
Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
RecruitingPhase 1
- St. Jude Children's Research Hospital, Memphis
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
RecruitingPhase 3
- Clinical Research Site, Memphis
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
RecruitingPhase 3
- Clinical Research Site, Memphis
About Attention Deficit Hyperactivity Disorder
Does your child have trouble paying attention? This may be a symptom of attention deficit hyperactive disorder (often called ADHD or ADD). Read more.
More about Attention Deficit Hyperactivity Disorder on MedlinePlus
Attention Deficit Hyperactivity Disorder trials in other cities
- Boston, MA10 studies
- Cincinnati, OH8 studies
- Philadelphia, PA6 studies
- Austin, TX6 studies
- Washington, DC5 studies
- Pittsburgh, PA5 studies
- Orlando, FL5 studies
- Las Vegas, NV5 studies
- New York City, NY4 studies
- Baltimore, MD4 studies
- Los Angeles, CA4 studies
- Durham, NC4 studies
Other studies in Memphis
- Cancer (all types)31 studies
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer22 studies
- Lung Cancer18 studies
- Sickle Cell Disease18 studies
- Acute Lymphoblastic Leukemia16 studies
- Acute Myeloid Leukemia15 studies
- Heart Failure13 studies
- Colorectal Cancer11 studies
- Soft Tissue Sarcoma11 studies
- Melanoma11 studies
- Prostate Cancer11 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.